December 23, 2015
A lens manufacturer filed a proposed class action in New Jersey federal court Tuesday over Valeant Pharmaceuticals International Inc.'s May acquisition of its sole competitor in the market for a material used in specialty contact lenses, saying the company is using its monopoly to inflate prices.